中文名：泊马度胺
英文名：Pomalidomide (CC-4047)
英文别名：4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione
纯度：10mM in DMSO
货号：P409134
包装：1ml
Cas号：19171-19-8
存储温度：-80℃储存
产品介绍：
Information
Pomalidomide (CC-4047) inhibits LPS-inducedTNF-αrelease withIC50of 13 nM in PBMCs. Pomalidomide can be utilized in PROTAC as a ligand for targetingE3 ligaseand inhibiting theE3 ligase protein cereblon (CRBN). Pomalidomide promotesapoptosisand cell cycle a
In vitro
Pomalidomide inhibits lipopolysaccharide (LPS) stimulated TNF-alpha release in human PBMC and in human whole blood with IC50 values of 13 nM and 25 nM, respectively. Pomalidomide inhibits the growth of T regulatory cells which is stimulated by IL-2 with an IC50 of ~1 μM. Treatment with Pomalidomide (6.4 nM-10 μM) increases the production of IL-2 in human peripheral blood T cells, and is slightly more potent in the CD4+ subset than in the CD8+ subset. Pomalidomide is significantly more potent than CC-5013 at elevating IL-2, IL-5, and IL-10 levels, but only slightly more potent than CC-5013 at elevating IFN-γ levels. Pomalidomide enhances SEE and Raji cells induced AP-1 transcriptional activity in Jurkat cells in a dose-dependent manner, with a maximal enhancement of 4-fold at 1 μM. Exposure of Raji cells to various concentrations of Pomalidomide (2.5-40 μg/mL) for 48 hours leads to a significant decrease in cell proliferation and DNA synthesis. There is a reduction of ~40% compared to vehicle-treated controls.
In vivo
Pomalidomide enhances the antitumor effect of rituximab against B-cell lymphomas in severe combined immunodeficient mice. Administration of Pomalidomide in combination with rituximab, gives the mice a median survival period of 74 days compared with 58 days of CC5013/rituximab treatment and 45 days of rituximab nonotherapy. The synergistic effect of Pomalidomide and rituximab can be completely abrogated by depletion of NK cells, supporting the proposal that NK cell expansion is one mechanism by which Pomalidomide may augment rituximab antitumor activity.
Cell Data
cell lines：PPC-1 cells
Concentrations：Dissolved in DMSO, final concentrations 2.5-40 μg/mL
Incubation Time：24 or 48 hours
Powder Purity:≥98%
查看阿拉丁官网此产品相关对应页面：https://www.aladdin-e.com/zh_cn/P409134.html
关键字： 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione
上海阿拉丁生化科技股份有限公司是A股上市公司（（股票代码：688179），专注于科研试剂的研发、生产和销售，已陆续建立多个工厂和研发中心。作为领军企业，阿拉丁始终坚持质量第一，连续13年被评为“最受欢迎试剂品牌”。
阿拉丁目前常备库存试剂产品品种超过7万种，SKU总数超过46万，产品线涵盖了化学试剂、生化试剂、药靶配体、蛋白质和抗体等多个领域，是国内少数化学试剂到生物试剂全面发展的国产试剂品牌，产品同步发布在我们国内外电商平台。